Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kenneth J Pienta

Showing results (511-520 of 519) with videos related to

Pageof 52
Sort By:
You have reached the last page of results.This site can display upto 519 results.
Evolutionary Applications|April 26, 2021
Identifying key questions in the ecology and evolution of cancerAntoine M Dujon, Athena Aktipis, Catherine Alix-Panabières, et al.
BMC Cancer|June 4, 2020
A phase II randomized trial of RAdium-223 dichloride and SABR Versus SABR for oligomEtastatic prostate caNcerS (RAVENS)Hamza Hasan, Matthew P Deek, Ryan Phillips, et al.
European Urology Oncology|September 21, 2025
Genomic Predictors of Response to Metastasis-directed Therapy With or Without Androgen Deprivation TherapyPhilip Sutera, Kim Van der Eecken, Yang Song, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 7, 2025
Outcomes of Radium-223 and Stereotactic Ablative Radiotherapy Versus Stereotactic Ablative Radiotherapy for Oligometastatic Prostate Cancers: The RAVENS Phase II Randomized TrialJarey H Wang, Alexander D Sherry, Soha Bazyar, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 23, 2025
National Cancer Institute's Working Group on Biochemically Recurrent Prostate Cancer: Clinical Trial Design ConsiderationsDavid J Einstein, Melissa L Abel, Jeanny B Aragon-Ching, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 24, 2022
Long-Term Outcomes and Genetic Predictors of Response to Metastasis-Directed Therapy Versus Observation in Oligometastatic Prostate Cancer: Analysis of STOMP and ORIOLE TrialsMatthew P Deek, Kim Van der Eecken, Philip Sutera, et al.
Cell|August 28, 2017
Integrative Clinical Genomics of Advanced Prostate CancerDan Robinson, Eliezer M Van Allen, Yi-Mi Wu, et al.
Cell|May 23, 2015
Integrative clinical genomics of advanced prostate cancerDan Robinson, Eliezer M Van Allen, Yi-Mi Wu, et al.
Oncotarget|December 25, 2014
Classification of current anticancer immunotherapiesLorenzo Galluzzi, Erika Vacchelli, José-Manuel Bravo-San Pedro, et al.
Pageof 52

Showing results (511-520 of 519) with videos related to

Sort By:
Pageof 52
You have reached the last page of results.This site can display upto 519 results.
Evolutionary Applications|April 26, 2021
Identifying key questions in the ecology and evolution of cancerAntoine M Dujon, Athena Aktipis, Catherine Alix-Panabières, et al.
BMC Cancer|June 4, 2020
A phase II randomized trial of RAdium-223 dichloride and SABR Versus SABR for oligomEtastatic prostate caNcerS (RAVENS)Hamza Hasan, Matthew P Deek, Ryan Phillips, et al.
European Urology Oncology|September 21, 2025
Genomic Predictors of Response to Metastasis-directed Therapy With or Without Androgen Deprivation TherapyPhilip Sutera, Kim Van der Eecken, Yang Song, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 7, 2025
Outcomes of Radium-223 and Stereotactic Ablative Radiotherapy Versus Stereotactic Ablative Radiotherapy for Oligometastatic Prostate Cancers: The RAVENS Phase II Randomized TrialJarey H Wang, Alexander D Sherry, Soha Bazyar, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 23, 2025
National Cancer Institute's Working Group on Biochemically Recurrent Prostate Cancer: Clinical Trial Design ConsiderationsDavid J Einstein, Melissa L Abel, Jeanny B Aragon-Ching, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 24, 2022
Long-Term Outcomes and Genetic Predictors of Response to Metastasis-Directed Therapy Versus Observation in Oligometastatic Prostate Cancer: Analysis of STOMP and ORIOLE TrialsMatthew P Deek, Kim Van der Eecken, Philip Sutera, et al.
Cell|August 28, 2017
Integrative Clinical Genomics of Advanced Prostate CancerDan Robinson, Eliezer M Van Allen, Yi-Mi Wu, et al.
Cell|May 23, 2015
Integrative clinical genomics of advanced prostate cancerDan Robinson, Eliezer M Van Allen, Yi-Mi Wu, et al.
Oncotarget|December 25, 2014
Classification of current anticancer immunotherapiesLorenzo Galluzzi, Erika Vacchelli, José-Manuel Bravo-San Pedro, et al.
Pageof 52